HOME >> MEDICINE >> NEWS
Pharmaceutical marketing tactics hold little sway with prescribing physicians

Pharmaceutical drug companies spend upward of $25 billion per year on promoting new drugs and distributing free samples to doctors, but new research shows such marketing devices have little impact on physicians and their prescribing behavior.

Direct-to-physician activities accounted for the bulk of spending, with $5.3 billion spent on a practice called "detailing" visits to physicians by pharmaceutical sales representatives in order to promote their firm's drugs. Free drug samples distributed during these visits were valued at roughly $16.4 billion.

"As the cost of prescription drugs continues to escalate, increased attention is being focused on the role of pharmaceutical marketing practices as a cause of higher drug prices," said Robert Jacobson, professor of marketing at the University of Washington Business School and co-author of the paper appearing in the December issue of Management Science.

"The concern that pharmaceutical marketing practices compromise physician integrity and have exacerbated increases in public health costs has prompted government actions at both the federal and state levels. The key public policy issue is the extent to which the industry's promotional tactics lead to an increase in appropriate versus inappropriate use of drugs in a cost- effective manner."

In the study, researchers analyzed data for three widely prescribed drugs issued by some 74,000 physicians over a two-year period to investigate the effect of pharmaceutical sales representatives on physician prescribing behavior. For each of the drugs in the study, Jacobson and Natalie Mizik, assistant professor of marketing at Columbia University, assessed the effects of changes in the numbers of sales calls and free samples on the number of new prescriptions the physician issued.

A detailing visit typically lasts two to five minutes, and information about a drug's composition, therapeutic value, proper dosage and potential s
'"/>

Contact: Nancy Gardner
nancylou@u.washington.edu
206-543-2580
University of Washington
7-Dec-2004


Page: 1 2 3

Related medicine news :

1. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
2. Pharmaceutical Achievers
3. Pharmaceutical industry still failing health needs of less-developed countries
4. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
5. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
6. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
7. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
8. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
9. Pharmaceuticals and personal care products
10. New publisher announced for Journal Of Pharmaceutical Sciences
11. American Association of Pharmaceutical Scientists tapped to manage PQRI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... , ... In the past, one of the first steps of a FUE ... reason many patients did not have a hair transplant. According to Dr. Parsa Mohebi, ... get the hairline they desire without shaving their head. This method was initially introduced ...
(Date:2/19/2019)... ... 19, 2019 , ... Conducting Advanced Root Cause Analysis CAPA ... FDAnews and Learning Plus**, Mar. 26-27, 2019 – Princeton, NJ, http://www.fdanews.com/capapc ... Feb. 26. , The greatest threat to compliance is ... overconfidence. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... The American ... (CMAC). Originally developed and launched by the Center for Case Management in 2000, ... management administrators, managers, supervisors and leaders. , “I created the CMAC credential ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Wachler, MD, has launched the first ever supplement to help support Keratoconus cornea ... to severe vision loss. The supplement, KC Defense, includes specific amounts Copper (Cu) ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... WEDI ... efficiencies in healthcare information exchange and a statutory advisor to the U.S. Department of ... President and CEO, Charles Stellar. The statement was issued following the release last week ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... As one of Delaware’s most-esteemed living artists, fine-arts painter ... in the morning to paint, it’s not work,” he said. “You get that feeling in ... SHARING SERENITY AND FULFILLMENT, Fine art has also given the former commercial artist a serenity ...
(Date:2/19/2019)... ... February 19, 2019 , ... Leading podiatrists in Miami, FL, ... pedicure services with their newest venture, Medicure Hand and Foot Spa. Medicure offers ... from Diabetes and Arthritis, and those undergoing Chemotherapy. , Preventing the many risks ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Syndrome by providing the scientific community with additional opportunities to further research into ... Chief Scientific Officer of the Foundation’s Scientific Advisory Board and the addition of ...
Breaking Medicine Technology:
Cached News: